Neuphoria Therapeutics NEUP
NASDAQ NEUP
$2.71 +0.02 (+0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Neuphoria Therapeutics (NEUP) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Neuphoria Therapeutics (NEUP) posted Depreciation & Amortization (CF) of $165,679 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $165,625 a year earlier and unchanged from the prior quarter.

Analysis

Neuphoria Therapeutics (NEUP) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics' Depreciation & Amortization (CF) came in at $662,955, unchanged from FY2025.

  • Annual Depreciation & Amortization (CF) shows a three-year compound annual growth rate of 0.0% (FY2023 to FY2026).
  • In prior fiscal years, Neuphoria Therapeutics' Depreciation & Amortization (CF) was $662,890 in FY2025 (unchanged), $662,991 in FY2024 (unchanged) and $663,192 in FY2023.
  • Quarterly Depreciation & Amortization (CF) has run from a low of $165,431 in fiscal Q3 2025 to a high of $166,121 in fiscal Q2 2025 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in two of the last eight quarters, with an average year-over-year change of 0.0%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior fiscal quarters was $165,695 (Q3 2026), $165,789 (Q2 2026) and $165,792 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Neuphoria Therapeutics 335.34 Mn 260.15 Mn - 165,679.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165,679.00
Mar 31, 2026 165,695.00
Dec 31, 2025 165,789.00
Sep 30, 2025 165,792.00
Jun 30, 2025 165,625.00
Mar 31, 2025 165,431.00
Dec 31, 2024 166,121.00
Sep 30, 2024 165,713.00
Jun 30, 2024 165,685.00
Mar 31, 2024 165,703.00
Dec 31, 2023 165,694.00
Sep 30, 2023 165,909.00
Dec 31, 2022 728,907.87
Dec 31, 2021 1.24 Mn
Dec 31, 2020 1.79 Mn
API Access

Neuphoria Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NEUP&period=max&api_key=YOUR_API_KEY